Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant609 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00434057 | Evaluation of Pigmented Skin Lesions With MelaFind(R) System | completed | Phase 3 | 1,383 | MELA Sciences, Inc.INDUSTRY | 1 | Feb 14, 2012 | clinicaltrials |
| NCT01011153 | Survey Study - Sensitivity Comparison Between MelaFind and Physician Group | completed | — | 241 | MELA Sciences, Inc.INDUSTRY | 0 | Feb 14, 2012 | clinicaltrials |
| NCT00925314 |
| A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma |
| unknown |
| Phase 2 |
| 20 |
| Cosmo BioscienceINDUSTRY |
| 1 |
| Feb 13, 2012 |
| clinicaltrials |
| NCT01409187 | IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jan 26, 2012 | clinicaltrials |
| NCT00002860 | SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma | completed | Phase 2 | 77 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 13, 2012 | clinicaltrials |
| NCT01106235 | Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic Melanoma | terminated | Phase 1 | 12 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 21, 2011 | clinicaltrials |
| NCT00002882 | Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma | completed | Phase 3 | 140 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 13, 2011 | clinicaltrials |
| NCT00006233 | Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Nov 30, 2011 | clinicaltrials |
| NCT00803374 | Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma | withdrawn | Phase 1 | 0 | Bristol-Myers SquibbINDUSTRY | 1 | Nov 21, 2011 | clinicaltrials |
| NCT00002763 | High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma | unknown | Phase 3 | 1,000 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 21 | Nov 16, 2011 | clinicaltrials |
| NCT00006385 | Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 2 | — | Eastern Cooperative Oncology GroupNETWORK | 1 | Nov 8, 2011 | clinicaltrials |
| NCT01092585 | Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH | unknown | Phase 2 | 27 | Genta IncorporatedINDUSTRY | 1 | Nov 8, 2011 | clinicaltrials |
| NCT00409383 | Abraxane and Temodar Plus Genasense in Advanced Melanoma | unknown | Phase 1 | 28 | Genta IncorporatedINDUSTRY | 1 | Nov 7, 2011 | clinicaltrials |
| NCT00518895 | Trial of Dacarbazine With or Without Genasense in Advanced Melanoma(AGENDA) | completed | Phase 3 | 300 | Genta IncorporatedINDUSTRY | 12 | Nov 7, 2011 | clinicaltrials |
| NCT00184288 | Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response. | withdrawn | — | 0 | Norwegian University of Science and TechnologyOTHER | 1 | Nov 2, 2011 | clinicaltrials |
| NCT00060710 | CP-461 in the Treatment of Patients With Advanced Melanoma | terminated | Phase 2 | 35 | Astellas Pharma IncINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00451880 | Study of XL281 in Adults With Solid Tumors | completed | Phase 1 | 180 | ExelixisINDUSTRY | 1 | Oct 13, 2011 | clinicaltrials |
| NCT00747825 | Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma | terminated | Phase 1 | 12 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Oct 12, 2011 | clinicaltrials |
| NCT01438658 | Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma(UM) | recruiting | — | 250 | Hadassah Medical OrganizationOTHER | 1 | Sep 28, 2011 | clinicaltrials |
| NCT00698100 | Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines | completed | Phase 1 | 18 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 16, 2011 | clinicaltrials |
| NCT00204581 | Intralesional Treatment With Interleukin-2 (Proleukin) in Soft Tissue Melanoma Metastases | completed | Phase 2 | 51 | University Hospital TuebingenOTHER | 1 | Aug 19, 2011 | clinicaltrials |
| NCT00324272 | Post-Operative Drainage Following Lymph Node Dissection | completed | Phase 4 | 74 | Oxford University Hospitals NHS TrustOTHER | 0 | Aug 11, 2011 | clinicaltrials |
| NCT00003690 | Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 48 | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00399113 | Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma | completed | Phase 1 | 12 | Pain TherapeuticsINDUSTRY | 1 | Jul 14, 2011 | clinicaltrials |
| NCT00734188 | Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma | completed | Phase 1 | 21 | Pain TherapeuticsINDUSTRY | 1 | Jul 14, 2011 | clinicaltrials |
| NCT00094653 | MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma | completed | Phase 3 | 1,783 | Bristol-Myers SquibbINDUSTRY | 13 | Jul 11, 2011 | clinicaltrials |
| NCT00003646 | Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 2 | 78 | VicalINDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00044356 | Phase II Trial of Allovectin-7® for Metastatic Melanoma | completed | Phase 2 | 133 | VicalINDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00580060 | Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity | completed | Early Phase 1 | 20 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00658437 | CY503 for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy | completed | Phase 2 | 31 | Cytavis Biopharma GmbHINDUSTRY | 1 | Jun 8, 2011 | clinicaltrials |
| NCT00471133 | Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation | completed | Phase 1 | 24 | Ichor Medical Systems IncorporatedINDUSTRY | 1 | Jun 7, 2011 | clinicaltrials |
| NCT00602199 | ABT-510 in Treating Patients With Metastatic Melanoma | completed | Phase 2 | 42 | Mayo ClinicOTHER | 0 | May 16, 2011 | clinicaltrials |
| NCT00897624 | Bone Marrow and Blood Samples From Patients With Metastatic Choroid Melanoma | completed | — | 15 | Institut CurieOTHER | 0 | May 13, 2011 | clinicaltrials |
| NCT00003091 | High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma | completed | Phase 2 | 40 | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 12, 2011 | clinicaltrials |
| NCT00033228 | Vaccine Therapy in Treating Patients With Stage IV Melanoma | completed | Phase 1 / Phase 2 | 19 | Mannkind CorporationINDUSTRY | 1 | May 12, 2011 | clinicaltrials |
| NCT00261404 | TNFerade™ Biologic Plus Radiation for Metastatic Melanoma | completed | Phase 2 | — | GenVecINDUSTRY | 1 | May 12, 2011 | clinicaltrials |
| NCT00002733 | Biological Therapy in Treating Patients With Metastatic Cancer | completed | Phase 2 | 30 | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 11, 2011 | clinicaltrials |
| NCT00667641 | Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | completed | Phase 1 | 16 | University of Medicine and Dentistry of New JerseyOTHER | 1 | May 10, 2011 | clinicaltrials |
| NCT00615095 | Differential Risks for Melanoma: p16 and DNA Repair | completed | — | 323 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 20, 2011 | clinicaltrials |
| NCT00700167 | Immune Responses To Antigen-Bearing Dendritic Cells in Patients With Malignancy | completed | Phase 1 | 43 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 20, 2011 | clinicaltrials |
| NCT00680589 | Patients With Mouse Tyrp2 DNA: A Phase I Trial to Assess Safety and Immune Response | completed | Phase 1 | 12 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00496223 | A Phase I/II Study of Sunitinib and Dacarbazine | terminated | Phase 1 / Phase 2 | 11 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 23, 2011 | clinicaltrials |
| NCT01168050 | Efficacy of Nilotinib in First or Second Line Treatment of Primary Melanomas Stage III Unresectable Melanomas.(NILOMEL) | unknown | Phase 2 | 25 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 8, 2011 | clinicaltrials |
| NCT00050102 | Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma | completed | Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 1 | Jan 28, 2011 | clinicaltrials |
| NCT01281722 | Role of SLURP-1 in Melanoma and Melanoma Stem Cells | unknown | — | 150 | National Taiwan University HospitalOTHER | 1 | Jan 24, 2011 | clinicaltrials |
| NCT00881049 | Trial of Imatinib (Gleevec®) in Selected Patients With Metastatic Melanoma | completed | Phase 2 | 1 | Peking UniversityOTHER | 1 | Jan 17, 2011 | clinicaltrials |
| NCT00422448 | Study to Test Genetic Alterations Among Different Dermoscopic Types of Melanocytic Nevi. | completed | N/A | 43 | Medical University of GrazOTHER | 1 | Jan 14, 2011 | clinicaltrials |
| NCT00746746 | A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma | unknown | Phase 2 | 30 | Ochsner Health SystemOTHER | 1 | Jan 13, 2011 | clinicaltrials |
| NCT00623402 | Combined Treatment of Sorafenib and Pegylated Interferon α2b in Stage IV Metastatic Melanoma(SoraPeg) | completed | Phase 2 | 55 | University Hospital Schleswig-HolsteinOTHER | 1 | Jan 12, 2011 | clinicaltrials |
| NCT01259934 | Nordic Adjuvant IFN Melanoma Trial | completed | Phase 3 | 855 | Karolinska InstitutetOTHER | 1 | Dec 14, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Feb 14, 2012source: clinicaltrials